Tel Aviv Sourasky Medical Center (Ichilov) signed a cooperation agreement with the Masaryk Memorial Cancer Institute (MMCI) in Brno, the Czech Republic’s largest cancer center, during a visit to the hospital by Czech Prime Minister Andrej Babiš.
The agreement covers cancer diagnosis, monitoring of hereditary risk and clinical trials, as well as joint research, researcher exchanges, training for medical staff and knowledge-sharing on radiation therapy, rehabilitation and cancer recovery. Professional talks between the two institutions have already begun, including on advanced radiation and proton therapy. MMCI deputy director Tomáš Kazda took part in the signing.
Babiš was joined by Deputy Prime Minister and Defense Minister Jaromír Zůna, Health Minister Adam Vojtěch and Sports Minister Boris Šťastný. The delegation was hosted by Ichilov director general Prof. Eli Sprecher and Prof. Ido Wolf, head of the hospital’s oncology division.
The visitors were briefed on Ichilov’s fast-track cancer diagnosis program, its radiation treatments using linear accelerators and MRI-guided radiation, and its plans to build a proton therapy center. They were also shown the hospital’s emergency preparedness and the artificial intelligence tools it has developed.
It is Ichilov’s second international cancer research agreement in about a month, after its partnership with Dana-Farber in Boston.
More information is available on the Ichilov website.


